Archean Chemical

Archean Chemical reported a mixed Q3 FY26. Standalone total income grew 2.4% YoY to INR 2,608.1 million, and 9M FY26 revenue increased 7.4% YoY to INR 7,840 million. However, profitability was significantly impacted, with Q3 standalone EBITDA declining 27% YoY to INR 698.6 million, and 9M standalone Net Profit down 1.6% YoY to INR 1,246 million. The company attributed these challenges to erratic monsoons, logistics disruptions, technical issues in plants, and lower crude prices affecting end markets, which continued to impact performance into early Q3.

The industrial salt segment demonstrated strong performance, with healthy volume growth year-on-year in Q3, selling 1.1 million tons and contributing 77% to standalone revenue. Elemental bromine demand remained robust with favorable pricing trends, contributing 23% to standalone revenue in Q3. However, the bromine derivatives (Acume) segment faced cost pressures due to rising elemental bromine prices, leading to a current utilization of 30-40%. Management is working to expand the product portfolio and aims to increase Acume utilization to 60-70%.

The Sulphate of Potash (SOP) project continues to experience delays, with pilot stage trials completed and progression to plant scale trials underway. Meaningful contributions from SOP are now anticipated in the latter half of FY27 due to technical issues related to feedstock quality. Similarly, the Oren/Idealis assets, acquired through the NCLT process, are still in the scaling-up phase, facing complexities related to local ecosystem challenges, community engagement, and labor groups. Management deferred specific revenue guidance for these assets, promising more clarity next quarter.

Archean Chemical is making significant strides in its advanced materials strategic initiatives. The SiCSem semiconductor project, a part of the Indian Semiconductor Mission, is on track with land allotted in Bhubaneshwar, and groundbreaking surveys and land leveling completed. The company also acquired 18.14% in Offgrid Energy Labs, a zinc bromide battery innovator, which plans to establish a 10-megawatt hour demo manufacturing facility in the U.K., indicating progress in the energy storage sector.

Despite strong demand, bromine production has been constrained by operational challenges, resulting in a backlog of approximately 6,500 tons. Management aims to restore production to a steady-state run rate of 18,000 tons next year and eventually achieve a 25,000-ton run rate in the medium term. They acknowledged that some older contracts would have a trailing impact on profitability due to cost increases, but expressed confidence in addressing the underlying operational issues related to brine quality and plant efficiency.

Analysts raised concerns about persistent project delays and potential management bandwidth issues. Management clarified that bandwidth is not a constraint, emphasizing their ability to implement operational fixes quickly, as demonstrated by changes made within a quarter. They attributed delays to complex technical challenges (SOP) and external ecosystem factors (Oren/Idealis), stating a focus on product development and customer acceptance cycles to drive utilization and growth across segments.